Evidence map›Paper›PMID 25385088›Full record

ArticleBioscience reports2014

A new structural insight into XPA-DNA interactions.

Benjamin Hilton, Nick Shkriabai, Phillip R Musich, Mamuka Kvaratskhelia, Steven Shell, Yue Zou

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Xeroderma pigmentosum A homolog fromJournal of biosciences · 2021
    Article
  3. XPA: DNA Repair Protein of Significant Clinical Importance.International journal of molecular sciences · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Progerin sequestration of PCNA promotes replication fork collapse and mislocalization of XPA in laminopathy-related progeroid syndromes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Benjamin Hilton*Department of Biomedical Sciences, East Tennessee State University, J.H Quillen College of Medicine, Johnson City, TN 37614, U.S.A.
Nick Shkriabai†Ohio State University Health Sciences Center, College of Pharmacy, Center for Retrovirus Research and Comprehensive Cancer Center, Columbus, OH 43210, U.S.A.
Phillip R Musich*Department of Biomedical Sciences, East Tennessee State University, J.H Quillen College of Medicine, Johnson City, TN 37614, U.S.A.
Mamuka Kvaratskhelia†Ohio State University Health Sciences Center, College of Pharmacy, Center for Retrovirus Research and Comprehensive Cancer Center, Columbus, OH 43210, U.S.A.
Steven Shell‡Department of Biochemistry, Center for Structural Biology, 5140 Biological Sciences/MRB III, Vanderbilt University, Nashville, TN 37232, U.S.A.
Yue Zou*Department of Biomedical Sciences, East Tennessee State University, J.H Quillen College of Medicine, Johnson City, TN 37614, U.S.A.
East Tennessee State University · USThe Ohio State University · USVanderbilt University · US

Funding

Structure and function of HIV-1 integraseR01AI062520 · NIAID · UNIVERSITY OF COLORADO DENVER · PI KVARATSKHELIA, MAMUKA · 2006 to 2020
$5.3M
RECOGNITION AND REPAIR OF UV DAMAGE TO HUMAN DNAR01CA086927 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ZOU, YUE · 2000 to 2011
$2.2M
Checkpoint Signaling and Repair of UV Damage to Human DNAR56CA086927 · NCI · EAST TENNESSEE STATE UNIVERSITY · PI ZOU, YUE · 2007 to 2007
$231k
NCI NIH HHS CA86927NCI NIH HHS R01 CA086927NIAID NIH HHS R01 AI062520
6 · The paper itself

Abstract

XPA (xeroderma pigmentosum group A) protein is an essential factor for NER (nucleotide excision repair) which is believed to be involved in DNA damage recognition/verification, NER factor recruiting and stabilization of repair intermediates. Past studies on the structure of XPA have focused primarily on XPA interaction with damaged DNA. However, how XPA interacts with other DNA structures remains unknown though recent evidence suggest that these structures could be important for its roles in both NER and non-NER activities. Previously, we reported that XPA recognizes undamaged DNA ds/ssDNA (double-strand/single-strandDNA) junctions with a binding affinity much higher than its ability to bind bulky DNA damage. To understand how this interaction occurs biochemically we implemented a structural determination of the interaction using a MS-based protein footprinting method and limited proteolysis. By monitoring surface accessibility of XPA lysines to NHS-biotin modification in the free protein and the DNA junction-bound complex we show that XPA physically interacts with the DNA junctions via two lysines, K168 and K179, located in the previously known XPA(98-219) DBD (DNA-binding domain). Importantly, we also uncovered new lysine residues, outside of the known DBD, involved in the binding. We found that residues K221, K222, K224 and K236 in the C-terminal domain are involved in DNA binding. Limited proteolysis analysis of XPA-DNA interactions further confirmed this observation. Structural modelling with these data suggests a clamp-like DBD for the XPA binding to ds/ssDNA junctions. Our results provide a novel structure-function view of XPA-DNA junction interactions.

Indexed as

Nucleic Acid ConformationProtein Structure, TertiaryBase SequenceBinding SitesDNADNA-Binding ProteinsHumansLysineModels, MolecularMolecular Sequence DataProtein BindingProteolysisSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationXeroderma Pigmentosum Group A ProteinDNADNA-Binding ProteinsLysineXeroderma Pigmentosum Group A ProteinXPA protein, human

Identifiers

PMID25385088
PMCPMC4266923
OpenAlexW2030896917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.